Canada Pension Plan Investment Board reduced its position in shares of athenahealth, Inc. (NASDAQ:ATHN) by 21.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,500 shares of the health services provider’s stock after selling 10,900 shares during the period. Canada Pension Plan Investment Board owned approximately 0.10% of athenahealth worth $5,692,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares in the last quarter. Morgan Stanley raised its position in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares in the last quarter. Clearbridge Investments LLC raised its position in shares of athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after buying an additional 347,133 shares in the last quarter. Credit Suisse AG raised its position in shares of athenahealth by 404.5% in the first quarter. Credit Suisse AG now owns 300,420 shares of the health services provider’s stock worth $33,854,000 after buying an additional 240,876 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of athenahealth by 4.5% in the first quarter. Vanguard Group Inc. now owns 3,047,282 shares of the health services provider’s stock worth $343,399,000 after buying an additional 130,569 shares in the last quarter.
Shares of athenahealth, Inc. (ATHN) opened at 139.28 on Tuesday. The stock has a 50 day moving average of $142.43 and a 200-day moving average of $126.26. The stock has a market capitalization of $5.56 billion, a price-to-earnings ratio of 176.75 and a beta of 1.77. athenahealth, Inc. has a 52-week low of $90.11 and a 52-week high of $158.66.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business had revenue of $301.10 million for the quarter, compared to analysts’ expectations of $298.68 million. During the same quarter in the previous year, the business posted $0.34 EPS. athenahealth’s revenue for the quarter was up 15.0% on a year-over-year basis. On average, equities research analysts predict that athenahealth, Inc. will post $1.91 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://stocknewstimes.com/2017/08/22/athenahealth-inc-athn-position-cut-by-canada-pension-plan-investment-board.html.
ATHN has been the subject of a number of recent analyst reports. Citigroup Inc. reiterated a “buy” rating and issued a $169.00 target price (up previously from $163.00) on shares of athenahealth in a research report on Monday, July 10th. BidaskClub raised shares of athenahealth from a “hold” rating to a “buy” rating in a report on Saturday, June 24th. Cantor Fitzgerald reissued a “buy” rating and issued a $118.00 price target (down from $135.00) on shares of athenahealth in a report on Thursday, April 27th. William Blair reissued a “market perform” rating on shares of athenahealth in a report on Friday, July 21st. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $135.00 price target on shares of athenahealth in a report on Monday, June 26th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the company. athenahealth has an average rating of “Hold” and an average target price of $148.64.
In other news, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $142.27, for a total transaction of $42,681.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. Insiders have sold a total of 14,874 shares of company stock worth $2,102,697 in the last quarter. 3.20% of the stock is currently owned by company insiders.
About athenahealth
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
